Federal health regulators paused enrollment in trials of Eli Lilly's coronavirus antibody treatment on Tuesday "out of an abundance of caution."
Officials did not explain why the pause was recommended, but a spokesperson for the company indicated it was "supportive of the decision" by an independent data safety monitoring board. Dr. Carlos del Rio, an infectious diseases expert at Emory University School of Medicine, told NBC News that "pauses are not infrequent in a clinical trial," especially one as "truncated" as the COVID-19 treatment development process.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Ukraine: Trump's mixed messagesFeature Trump reverses a Pentagon freeze on Patriot missiles to Ukraine as Russia ramps up air attacks
-
Diddy: An abuser who escaped justice?Feature The jury cleared Sean Combs of major charges but found him guilty of lesser offenses
-
Death from above: Drones upend rules of war in UkraineFeature The world's militaries are paying close attention to drone use in the Russia-Ukraine war
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measlesSpeed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
